
Research Initiatives
NBRL-IIT Kharagpur, keeps a vision of "Translating Nanotechnology for Biotechnological Application" and continuously working in this aspect. Few of the initiatives are as:
Regenerative Medicine

3D Bioprinted Resorbable Cardiovascular Stent
NBRL is actively developing nanoengineered 3D printed thinner bioresorbable for controlled degradation, ffficient endothelialization, antithrombotic, and antiproliferation of vascular smooth muscle cells to treat atherosclerosis:3DNanoResStent.
This work is funded by ICMR.
Hospital Collaborator: SCTIMST, Thiruvananthapuram

3D Bioprinted Microneedle-Hydrogel System for Second Degree Burn Management
NBRL is actively developing 3D Printed bioresorbable microneedle array-based sutureless breathable dermal-substitute system for second-degree burn wounds to treat microbial infection, hypertrophic scar, and with skin regenerative properties (3DBioResMiNee).
This work is funded by ICMR.
Hospital Partner: SCTIMST, Thiruvananthapuram

Acne Patches
NBRL is developing bioinspired multifunctional nanostructured hydrogel of hyaluronic acid and carboxymethyl cellulose as a dry and thin acne patch.

Extracellular Vesicles for Diabetic Wound Management
NBRL is developing bioresorbable, breathable hydrogel enriched with drug-loaded extracellular vesicles for diabetic wounds to treat microbial infection, inflammation, scar, along with dermal-remodeling, regeneration, and angiogenesis properties (ExoHydroHeal). This work is proposed fur funding to ICMR.
Hospital Collaboration: ILBS, New Delhi

Nanofibers for Biomedical Applications
NBRL is constantly developing biomedical applications of nanofibers e.g. scaffolds, vascular tissue engineering, bone tissue engineering, biosensors, drug delivery, ECM biomimicking, and wound healing.

Lipid Nanomaterials for Cancer Therapeutics
NBRL is developing Lipid Nanomaterials liposomes, lipid nanoemulsions, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and lipid-polymer hybrid nanoparticles for therapeutics enhancement in cancer.

Drug Delivery